Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Q2 Revenues Up 8 Percent, Losses Down 41 Percent

NEW YORK, July 20 (GenomeWeb News) - Gene Logic today reported increased revenues and declining losses for the second quarter of 2005.


Revenues for the quarter totaled $20.1 million, up 8 percent from $18.6 million during the same period a year ago. Of those, $14.2 million came from genomics and toxicogenomics services, a 12-percent increase, while revenues from nonclinical contract research services decreased 2 percent, to $5.8 million.


The company's research and development expenses for the quarter were $1.4 million, up from $400,000 during the year-ago period.


Gene Logic's net loss for the quarter was $2.6 million, or $.08 per share, down 41 percent from $4.4 million, or $.14 per share, during last year's second quarter. Part of this improvement came from $500,000 in savings compared to last year's quarter due to a new income tax treaty between the USand Japan that came into effect July 1, 2004.


As of June 30, Gene Logic had $69 million in cash and cash equivalents, and $29 million in marketable securities.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.